Cargando…
The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
Many neurodegenerative diseases present with progressive neuronal degeneration, which can lead to cognitive and motor impairment. Early screening and diagnosis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) are necessary to begin treatment before the onse...
Autores principales: | Pawlik, Patrycja, Błochowiak, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926361/ https://www.ncbi.nlm.nih.gov/pubmed/33671562 http://dx.doi.org/10.3390/diagnostics11020371 |
Ejemplares similares
-
Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson's Disease
por: Salaramoli, Sanaz, et al.
Publicado: (2023) -
Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020) -
Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
por: Schepici, Giovanni, et al.
Publicado: (2020) -
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
por: Ashton, Nicholas J., et al.
Publicado: (2019) -
Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
por: Sabaei, Masoomeh, et al.
Publicado: (2023)